London, England, United Kingdom
European Patent Attorney in the Biotechnology & Life Sciences team. PhD Immunologist with >5 years laboratory experience including 2 years in industry.
Investigated the immune system of neonates born to SARS-CoV-2 exposed mothers (Gee S, et al. Nature Immunology et al., 2021) Researched neonatal T cell development, function and the epigenetic control in health and disease.
Jan 19-Sep 19: Cell Assay Development. Developed a CRISPR co-culture screen for immunooncology (Gee S, et al. SLAS Discov. 2020 Jul;25(6):581-590). May 18-Jan 19: Oncology Research (MedImmune) & Oncology Bioscience (AstraZeneca) Established an in vitro model to investigate TLR mechanisms. Sep 17-Mar 18: Genetic Toxicology Investigated using 3D bone marrow models (including organ-on-a-chip) for genetic toxicology testing (David, R., & Gee, S. et al. 2021. Three dimensional and microphysiological bone marrow models detect in vivo positive compounds. Scientific Reports).
Title: Evaluating methodologies to investigate the effects of malaria infection on the immune response to Ebola vaccine, EBOVAC
Processed antigen tests and microscopy, culture & sensitivity (MC&S) tests. Prioritised, sorted and labelled clinical specimens. Biosafety level 3 trained.